Andrew Chamberlin is a trial attorney with a broad national practice. Andrew has handled pharmaceutical and medical device, product liability, and catastrophic injury defense cases, as well as the prosecution and defense of commercial, construction, and intellectual property disputes.
Recently, Andrew has handled multiple matters involving lithium‑ion batteries, including fire investigations, construction and EPC disputes, and commercial claims alleging the defective design and manufacture of batteries and battery management systems.
Andrew has tried “bet the company” jury trials but is equally prepared to consider a range of business and legal alternatives. He understands that the best outcome for the client is not always achieved through a favorable verdict obtained at great risk and expense. Andrew has helped clients implement pre‑litigation investigations and settlement programs, allowing disputes to be resolved confidentially while preserving business reputation.
Andrew has significant arbitration experience and recently obtained an eight‑figure award in an EPC dispute before an AAA panel. He frequently represents European multinational corporations in matters pending in the United States, including AAA arbitrations, ICC proceedings, cross‑border discovery issues, disputes involving the French blocking statute, and GDPR compliance. His innovative thinking is illustrated by a discovery ruling permitting simultaneous compliance with the Federal Rules of Civil Procedure and the French Blocking Statute in Salt River Project Agricultural Improvement and Power District v. Trench France SAS, 303 F. Supp. 1004 (2018).
Andrew is actively involved in the global legal community. He is a past President of the International Association of Defense Counsel and served as Dean of the IADC’s 2025 Corporate Counsel College. He has also served as faculty for the IADC Trial Academy at Stanford University.
